Rethinking Value in Obesity Therapy

João L. Carapinha, Ph.D.

Table of Contents

Poll 23 – 2026

3
Rethinking Value in Obesity Therapy

I’ve been looking at how new incretin therapies are changing the conversation around obesity treatment, especially when long-term use, weight regain, and regional differences all affect value. It raises an important question about what decision-makers should prioritize most as these therapies expand. Share your insights by voting below!

 

What should matter most when assessing the value of new obesity therapies?

Table of Contents